Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
Sponsor: Universitaire Ziekenhuizen KU Leuven
This NA trial investigates Neuro-Degenerative Disease and is currently ongoing. Universitaire Ziekenhuizen KU Leuven leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Enrolling By Invitation NA
-
Aug 2024 — Sep 2024 [monthly]
Enrolling By Invitation NA
Status: Unknown → Enrolling By Invitation
-
Jul 2024 — Aug 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Oct 2020 [monthly]
Enrolling By Invitation NA
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .